Tirzepatide CAS 2023788-19-2 Vail Lyophilized powder Weight loss peptide
No.2023788-19-2
Description Tirzepatide injection is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. Tirzapatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide injection is also used to help lose weight and keep the weight off in patients with obesity caused by certain conditions.
How Do They Work for Weight Loss? Both tirzepatide and semaglutide work by suppressing appetite and slowing down the movement of food through your digestive system. This combination leads to fewer calories consumed throughout the day. But the two drugs differ in their mechanisms, making tirzepatide potentially more effective for some individuals. Tirzepatide for Weight Loss
Tirzepatide goes a step further by targeting both the GLP-1 and GIP receptors. The added activation of GIP receptors means tirzepatide can enhance the way your body processes sugar and fat. This leads to not only greater weight loss but also more significant improvements in metabolic health, including better insulin sensitivity and fat burning
Tirzepatide’s Weight Loss Results Tirzepatide has shown even more remarkable weight loss outcomes. The SURMOUNT-1 trial studied the effects of tirzepatide in adults with obesity and found: .People taking 5 mg of tirzepatide lost about 15% of their body weight. .Those on the 10 mg dose lost 19.5% of their body weight. .The highest dose, 15 mg, resulted in an average weight loss of 20.9%. This is an incredible amount of weight loss from a medication alone. To put it into perspective, weight loss surgeries like gastric bypass typically lead to 25-30% total body weight loss, meaning tirzepatide approaches surgical-level results.
